Hellmuth S, Stemmann O
EMBO J. 2024; 43(21):5237-5259.
PMID: 39271794
PMC: 11535040.
DOI: 10.1038/s44318-024-00228-9.
Yan L, Yuan X, Liu M, Chen Q, Zhang M, Xu J
EMBO J. 2024; 43(12):2424-2452.
PMID: 38714893
PMC: 11182772.
DOI: 10.1038/s44318-024-00104-6.
Rankin B, Rankin S
Biology (Basel). 2024; 13(4).
PMID: 38666870
PMC: 11048021.
DOI: 10.3390/biology13040258.
Sen Gupta A, Seidel C, Tsuchiya D, McKinney S, Yu Z, Smith S
Nat Commun. 2023; 14(1):7947.
PMID: 38040722
PMC: 10692335.
DOI: 10.1038/s41467-023-42980-2.
Quadri R, Rotondo G, Sertic S, Pozzi S, DellOca M, Guerrini L
iScience. 2023; 26(10):108011.
PMID: 37841592
PMC: 10570125.
DOI: 10.1016/j.isci.2023.108011.
Hornerin mediates phosphorylation of the polo-box domain in Plk1 by Chk1 to induce death in mitosis.
Song H, Kim E, Hong J, Gwon D, Kim J, Bae G
Cell Death Differ. 2023; 30(9):2151-2166.
PMID: 37596441
PMC: 10482915.
DOI: 10.1038/s41418-023-01208-y.
Genome control by SMC complexes.
Hoencamp C, Rowland B
Nat Rev Mol Cell Biol. 2023; 24(9):633-650.
PMID: 37231112
DOI: 10.1038/s41580-023-00609-8.
Defining a core configuration for human centromeres during mitosis.
Sen Gupta A, Seidel C, Tsuchiya D, McKinney S, Yu Z, Smith S
bioRxiv. 2023; .
PMID: 37214893
PMC: 10197669.
DOI: 10.1101/2023.05.10.539634.
A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle.
Li H, Dong L, Jin M, Li Q, Wang X, Jia M
Molecules. 2023; 28(3).
PMID: 36770809
PMC: 9920120.
DOI: 10.3390/molecules28031141.
Multiple Roles of PLK1 in Mitosis and Meiosis.
Kalous J, Aleshkina D
Cells. 2023; 12(1).
PMID: 36611980
PMC: 9818836.
DOI: 10.3390/cells12010187.
Somatic mosaicism in -associated cohesinopathies: Expansion of the genotypic and phenotypic spectrum.
Schmidt J, Dreha-Kulaczewski S, Zafeiriou M, Schreiber M, Wilken B, Funke R
Front Cell Dev Biol. 2022; 10:1025332.
PMID: 36467423
PMC: 9710855.
DOI: 10.3389/fcell.2022.1025332.
Topoisomerase II poisons inhibit vertebrate DNA replication through distinct mechanisms.
Van Ravenstein S, Mehta K, Kavlashvili T, Byl J, Zhao R, Osheroff N
EMBO J. 2022; 41(12):e110632.
PMID: 35578785
PMC: 9194788.
DOI: 10.15252/embj.2022110632.
α-Santalol functionalized chitosan nanoparticles as efficient inhibitors of polo-like kinase in triple negative breast cancer.
Zhang J, Wang Y, Li J, Zhao W, Yang Z, Feng Y
RSC Adv. 2022; 10(9):5487-5501.
PMID: 35498298
PMC: 9049642.
DOI: 10.1039/c9ra09084c.
Maternal Smc3 protects the integrity of the zygotic genome through DNA replication and mitosis.
Yueh W, Singh V, Gerton J
Development. 2021; 148(24).
PMID: 34935904
PMC: 8722392.
DOI: 10.1242/dev.199800.
Cohesin Mutations in Cancer: Emerging Therapeutic Targets.
Antony J, Chin C, Horsfield J
Int J Mol Sci. 2021; 22(13).
PMID: 34202641
PMC: 8269296.
DOI: 10.3390/ijms22136788.
Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer.
Kressin M, Fietz D, Becker S, Strebhardt K
Cells. 2021; 10(5).
PMID: 34065956
PMC: 8151477.
DOI: 10.3390/cells10051176.
Ssu72 Dual-Specific Protein Phosphatase: From Gene to Diseases.
Hwang S, Kim M, Lee C
Int J Mol Sci. 2021; 22(7).
PMID: 33917542
PMC: 8038829.
DOI: 10.3390/ijms22073791.
Structure and Function of the Separase-Securin Complex.
Luo S, Tong L
Subcell Biochem. 2020; 96:217-232.
PMID: 33252730
PMC: 7891875.
DOI: 10.1007/978-3-030-58971-4_4.
The CINs of Polo-Like Kinase 1 in Cancer.
Cunningham C, MacAuley M, Vizeacoumar F, Abuhussein O, Freywald A, Vizeacoumar F
Cancers (Basel). 2020; 12(10).
PMID: 33066048
PMC: 7599805.
DOI: 10.3390/cancers12102953.
Polo-like kinase 1 (Plk1) is a positive regulator of DNA replication in the system.
Ciardo D, Haccard O, Narassimprakash H, Chiodelli V, Goldar A, Marheineke K
Cell Cycle. 2020; 19(14):1817-1832.
PMID: 32573322
PMC: 7469467.
DOI: 10.1080/15384101.2020.1782589.